How many hospitals have both of these and know how to work them together? In simple words; Where the fuck is the protocol so your hospital will do it right the first time?
High-Definition Transcranial Direct Current with Electrical Theta Burst on Post-Stroke Motor Rehabilitation: A Pilot Randomized Controlled Trial
Abstract
Background:
High-definition
transcranial electrical theta burst superimposing direct current
stimulation (HD-tDCS-eTBS) not only incorporates the therapeutic
advantages of tDCS and TBS but enhances stimulation focality and
practicality. However, the applicability of this innovative
neuromodulatory device in post-stroke rehabilitation remains uncertain.
Objective:
This
study aimed to assess the efficacy and safety of the HD-tDCS-eTBS on
upper extremity (UE) motor function in patients with chronic stroke.
Methods:
A
patient-blinded, randomized controlled study was conducted. Twenty-four
participants were randomly assigned into either the active HD-tDCS-eTBS
group or sham HD-tDCS-eTBS group. Both groups received 20 minutes of
active/sham HD-tDCS-eTBS combined with 30 minutes of conventional UE
rehabilitation each time, 3 times a week for 4 weeks. Outcome measures
including the Fugl-Meyer Assessment of Upper Extremity, Wolf Motor
Function Test, Jebsen-Taylor Hand Function Test, Finger-Nose Test, and
Modified Ashworth Scale were assessed before and immediately after the
intervention period.
Results:
Spasticity of shoulder adductor (P = .05), elbow extensor (P = .04), and thumb flexor (P < .01)
were significantly reduced in the active HD-tDCS-eTBS group versus the
sham group. Nonsignificant trends in the improvements of most other
outcome measures were in favor of the active HD-tDCS-eTBS group with
moderate to large effect sizes (P = .06–.26, ηp2 = 0.06–0.16).
No severe adverse events except for slight skin redness under the
stimulus electrode was detected after the HD-tDCS-eTBS.
Conclusions:
Our findings support that HD-tDCS-eTBS is safe and has therapeutic potential for post-stroke UE motor rehabilitation.
Trial registration:
ClinicalTrials.gov (ID: NCT04278105).
No comments:
Post a Comment